Syncona (SYNC.L) posted a first half loss after tax of 75.0 million pounds compared to a loss of 53.7 million pounds, last year. Loss per share was 11.61 pence compared to 8.
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by...
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by...
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.
If you are in any doubt as to the action to be taken, please seek your own financial advice from...
Nov 17, 2022 / 09:00AM GMTMartin Patrick Murphy - Syncona Limited - CEO Well, good morning, everyone. Welcome to Syncona's interims. I'm Martin Murphy. I'm join
Oct 24, 2022 / 11:30AM GMTOperator Good morning, and welcome to the AGTC Conference Call. Today's call is being recorded. Before we get started, I would like to
Nov 11, 2021 / 09:00AM GMTOperator Good day, ladies and gentlemen, and welcome to Syncona's Interim Results 2021-'22. (Operator Instructions) I would like to ad
Jun 17, 2021 / 08:00AM GMTOperator Good day, ladies and gentlemen, and welcome to Syncona's Full Year Results 2021 Presentation. (Operator Instructions) I will
THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.
If you are in any doubt as to the action to be taken, please seek your own financial advice from... | May 26, 2021